ADVANCED MOBILITY SUPPORT

Product description

Exhibitor Profile

ADVANCED MOBILITY SUPPORT

COMPOSITIONSmall Dogs
(up to 5 kg)Medium Dogs
(5 - 15 kg)Large Dogs
(15 - 30 kg)Dogs
(> 30 kg)CatsGlucosamine100 mg200 mg400 mg600 mg75 mgChondroitin sulphate100 mg200 mg400 mg600 mg75 mgRosemary oil10 mg20 mg40 mg60 mg7.5 mgOmega-3162 mg324 mg648 mg972 mg121.5 mgOmega-67.2 mg14.4 mg28.8 mg43.2 mg5.4 mgVitamin E acetate20 mg40 mg80 mg120 mg15 mgVitamin B1 HCl0.1 mg0.2 mg0.4 mg0.6 mg0.075 mgZinc chelate of
glycine, hydrate11.76 mg23.52 mg47.04 mg70.56 mg8.82 mgMethly sulphonyl methane (MSM)100 mg200 mg400 mg600 mg75 mgHyaluronic acid1 mg2 mg4 mg6 mg0.75 mgProduct (1 pump
provides 2 mL)2 mL4 mL8 mL12 mL1.5 mL

BENEFITS

Zoleant Hip & Joint is specifically formulated for dogs and cats to support and maintain healthy joints, muscles and cartilage, and assist in recovery from injury. Periods of high activity place additional demands and wear on the mobility of the animal whereas the aging process slows down the natural renewal in older dogs.

Additional key formulation benefits are:

Omega 3 – relieves inflammation and pain caused by arthritis, aids in the proper brain and eye development of puppies and kittens. Improves cognitive function in older pets.
Hyaluronic Acid – restores joint health, repairs damage to the joints as well as supports the life of the cartilage cushion. In addition it is important for growing shiny coats, promoting healthy skin and maintaining healthy gum and eye health.
MSM (methyl sulfonyl methane) – is essential to relieve pain, discomfort and swelling in a variety of hip, bone and joint disorders.
Glucosamine & Chondroitin – together they repair joints, stimulate cartilage growth and thicken synovial fluid, thus improving mechanical joint function and slowing the progression of arthritis.
Zinc – provides an anti-inflammatory and antioxidant activity which is an ideal complement for joint inflammation.

DIRECTIONS FOR USE

For ensured natural mobility support, a one-month protocol is recommended according to the matrix provided above.

One pump is equivalent to 2 mL of product.

The solution should be administered directly into the mouth or by mixing with the pet’s food.

COMMERCIAL PRESENTATION

Zoleant Hip & Joint is available in 4 oz. (118 mL) and 8 oz. (237 mL) packaging options.

ABOUT US

Zoleant Pharmaceuticals International is passionate about the development and global marketing of niche alternative brand pharmaceuticals, unique nutritional supplements, and companion animal products. This dedication ensures access to affordable, high quality animal health products for all.

The commitment and knowledge of our professionals not only allows for Zoleant Pharmaceuticals to create generic pharmaceuticals, but innovative veterinary products. With a true hands-on approach, we focus on the needs of various markets and territories in developing and expanding our product range.

Our Mission

Contribute to the enhancement of the quality of life globally by focusing on the wellbeing of animals and achieving this through our veterinary products.

Our Vision

Building the foundation to becoming the leading provider of alternative brand medicines, while developing and commercializing new animal health products.

Areas of Focus

In order for Zoleant Pharmaceuticals International to fulfill its mission and achieve strategically defined objectives, the Company must methodically concentrate on key focus areas and their developments. These critical focus areas for implementing the Zoleant strategy are:

Quality & Safety: consistently complying with the standards and requirements of those regional authorities in which we have activities while ensuring that the Zoleant understandings of high quality and product safety are met. This is an indispensible aspect of the global pharmaceutical industry.

Efficiency & Flexibility: in order to react to the rapid changes in the global socio and economic conditions, Zoleant seamlessly co-operates with different internal and external divisions to achieve the highest level of customer satisfaction.

Partnerships: Zoleant operations are entirely utilized through our worldwide networks in which the well-managed and transparent partnerships allow for a competitive advantage. It is these partnerships that expedite and push for further global expansion.

Strong Developing Portfolio: product development and their effective launching is a crucial key for the success of the Company and our partners. This requires continuous input from our global partners while our internal teams strive for opportunities in continuous research and development.

Team Culture: Zoleant aspires to provide an attractive and responsible workplace to promote the well-being and continuous development of its personnel through team work, social activities, continued education, and growth.

Strategic Goals

To ensure continuous growth with maximized efficiency, Zoleant has put into place the following various strategic targets that are monitored with clearly defined indicators:

Innovation: to be able to develop and launch a steady stream of new innovative and cost-effective medicines to our customers.

Communication: being committed to working closely with our global shareholders, partners, and distributors to understand the needs of the customers in those territories to ensure an exceptional level of satisfaction and Zoleant brand awareness.

Sustainability: continuous development to achieve corporate, environmental and operational improvements for ensured sustainability with a focus on occupational safety.

Growth: in order for Zoleant to develop and take manageable risks, the Company must grow faster than our markets of operation. This is an essential business model of the Company as a whole and is not just limited to our geographic strategic partners or the product offerings.